MIG7 Regulates the Vasculogenic Mimicry Formation in Hepatocellular Carcinoma then Effects the Metastasis Potential of HCC

QU Bo, YU Fei, SHENG Guan-nan. et al

Abstract

To investigate the expression of migration-inducing gene 7 (MIG7) in different HCC lines and its relationship with vasculogenic mimicry (VM) formation and metastatic potentiality. Methods Employing immunostaining to detect MIG7 protein expression and VM formation in 40 matched pairs of primary and metastatic HCC specimens from 40 patients, and investigating the correlation of VM formation with MIG7 protein expression. Detecting VM formation in HCC lines with different metastatic ability (MHCC-97H, MHCC-97L, Huh-7) and human normal hepatocyte line (L-02) through three-dimensional culture, and detecting MIG7 mRNA expression with RT-PCR, investigating the correlation of MIG7 protein expression with VM formation and HCC metastatic potentiality with Western blot assay; screening the HCC cell line with high MIG7 expression. Results In 40 matched pairs of HCC tissue, there was a significant positive correlation between MIG7 protein expression and VM formation ( rs=0.595, P<0.01). The capability of VM formation of MHCC-97H with high metastatic potentiality was stronger than that of MHCC-97L with low metastatic potentiality and Huh-7 with non-metastatic potentiality, and there was no VM formation in L-02. The result of RT-PCR and Western blot assay indicated the same. Conclusion MIG7 expression in HCC tissue is high and correlated positively with VM formation. MIG7 expression in different HCC cell lines is coincident with theirs VM formation, invasion and metastasis. MIG7 is a potential target for inhibiting the invasion and metastasis of HCC.

 

Keywords: Vasculogenic mimicry MIG7, Angiogenesis, Hepatocellular carcinoma, Invasion and metastasis 

 

Full Text:

PDF


References


DE SOUZA JA, HUNT B, ASIRWA FC, et al. Global Health Equity; Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries. J Clin Oncol. 2016, 34 ( 1) : 6-13.

CHEN W, ZHENG R, BAADE PD. et al. Cancer statistics in China, 2015. С A Cancer J Clin, 2016,66(2): 115-132.

TORRE LA, SAUER AM, CHEN MS, et al. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016 : converging incidence in males and females . CA Cancer J Clin.2016.66(3): 182-202.

N UT H A LAP ATI AKHSI. THULUVATH PJ. Recurrence of hepatocellular carcinoma following liver transplantation within milan criteria. //Disease recurrence after liver transplantation. New York: Springer.2016:153-164.

QU B. GUO L. MA J, et al. Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system. Med Hypotheses,2010,74(2) :360-361.

AGGAN HE, YOUNIES L. HASSONA E, et al. P0342: cancer stem cells and vasculogenic mimicry in hepatitis С virus-related hepatocellular carcinoma; relation to tumor progression. J Hepatol,2015,62;S438[2016-10-12]. http;// doi. org/10. 1016/s0168-8278( 15)30556.

SUN B, ZHANG S, ZHANG D. et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep,2006,16(4):693-698.

HOMY, LIANG CM, LIANG SM. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis . Oncotarget ,2015 ,6( 1) ;381-393.

PETTY AP, GARMAN KL, WINN VD, et al. Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation. Am J Pat hoi, 2007,170(5): 1763-1780.

XUE R, LI R, GUO H, et al. Variable extent of intratumor heterogeneity revealed by genomic sequencing of multiple lesions in patients with hepatocellular carcinoma. Gastroenterology .2016 ,150( 1) :998-1008.

MANIOTIS AJ, FOLBERG R. HESS A, et al. Vascular channel formation by human melanoma cells in -vivo and in vitro i vasculogenic mimicry. Am J Pathol ,1999,155(3); 739- 752.

LIU K. SUN B, ZHAO X, et al. Hypoxia promotes vasculogenic mimicry formation by the Twistl-Bmil connection in hepatocellular carcinoma. Int J Mol Med,2015, 36(3);783-7 91.

STEEG PS. Angiogenesis inhibitors: motivators of metastasis? Nat Med,2003,9(7) :822-823.


Refbacks

  • There are currently no refbacks.